Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-059840
Filing Date
2026-02-19
Accepted
2026-02-19 18:26:34
Documents
1
Period of Report
2026-02-19

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 8499
  Complete submission text file 0001193125-26-059840.txt   9880
Mailing Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065
Business Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065 240-327-0603
Arcellx, Inc. (Issuer) CIK: 0001786205 (see all company filings)

EIN.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 2116 GOSSAMER AVE REDWOOD CITY CA 94065
Business Address
Gilson Michelle (Reporting) CIK: 0001930862 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41259 | Film No.: 26655977